Statistics

Total Visits

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup109

Select a period of time:

Number of views in the range

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup37

Views

Views
December 20256
January 20263
February 20260
March 20268
April 20265
May 20263
June 202612
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Netherlands7
United Kingdom5
Spain2
Brazil2
Angola1
Argentina1
China1
Germany1
Mauritius1
 

Top cities views

Views
Groningen7
Madrid2
Araras1
Ashburn1
Brooklyn1
Carapicuíba1
Córdoba1
Hoffman Estates1
Istanbul1
Lima1